Taljaard Monica, Hemming Karla, Shah Lena, Giraudeau Bruno, Grimshaw Jeremy M, Weijer Charles
1 Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
2 School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, ON, Canada.
Clin Trials. 2017 Aug;14(4):333-341. doi: 10.1177/1740774517703057. Epub 2017 Apr 8.
Background/aims The use of the stepped wedge cluster randomized design is rapidly increasing. This design is commonly used to evaluate health policy and service delivery interventions. Stepped wedge cluster randomized trials have unique characteristics that complicate their ethical interpretation. The 2012 Ottawa Statement provides comprehensive guidance on the ethical design and conduct of cluster randomized trials, and the 2010 CONSORT extension for cluster randomized trials provides guidelines for reporting. Our aims were to assess the adequacy of the ethical conduct and reporting of stepped wedge trials to date, focusing on research ethics review and informed consent. Methods We conducted a systematic review of stepped wedge cluster randomized trials in health research published up to 2014 in English language journals. We extracted details of study intervention and data collection procedures, as well as reporting of research ethics review and informed consent. Two reviewers independently extracted data from each trial; discrepancies were resolved through discussion. We identified the presence of any research participants at the cluster level and the individual level. We assessed ethical conduct by tabulating reporting of research ethics review and informed consent against the presence of research participants. Results Of 32 identified stepped wedge trials, only 24 (75%) reported review by a research ethics committee, and only 16 (50%) reported informed consent from any research participants-yet, all trials included research participants at some level. In the subgroup of 20 trials with research participants at cluster level, only 4 (20%) reported informed consent from such participants; in 26 trials with individual-level research participants, only 15 (58%) reported their informed consent. Interventions (regardless of whether targeting cluster- or individual-level participants) were delivered at the group level in more than two-thirds of trials; nine trials (28%) had no identifiable data collected from any research participants. Overall, only three trials (9%) indicated that a waiver of consent had been granted by a research ethics committee. When considering the combined requirement of research ethics review and informed consent (or a waiver), only one in three studies were compliant. Conclusion The ethical conduct and reporting of key ethical protections in stepped wedge trials, namely, research ethics review and informed consent, are inadequate. We recommend that stepped wedge trials be classified as research and reviewed and approved by a research ethics committee. We also recommend that researchers appropriately identify research participants (which may include health professionals), seek informed consent or appeal to an ethics committee for a waiver of consent, and include explicit details of research ethics approval and informed consent in the trial report.
背景/目的 阶梯楔形整群随机设计的应用正在迅速增加。这种设计常用于评估卫生政策和服务提供干预措施。阶梯楔形整群随机试验具有独特的特征,使其伦理解读变得复杂。2012年《渥太华声明》为整群随机试验的伦理设计和实施提供了全面指导,2010年《整群随机试验CONSORT扩展版》为报告提供了指南。我们的目的是评估迄今为止阶梯楔形试验伦理实施和报告的充分性,重点关注研究伦理审查和知情同意。方法 我们对截至2014年在英文期刊上发表的卫生研究中的阶梯楔形整群随机试验进行了系统评价。我们提取了研究干预和数据收集程序的详细信息,以及研究伦理审查和知情同意的报告。两名评审员独立从每个试验中提取数据;差异通过讨论解决。我们确定了在整群层面和个体层面是否存在任何研究参与者。我们通过将研究伦理审查和知情同意的报告与研究参与者的存在情况列表来评估伦理实施情况。结果 在32项确定的阶梯楔形试验中,只有24项(75%)报告了由研究伦理委员会进行的审查,只有16项(50%)报告了获得任何研究参与者的知情同意——然而,所有试验在某种程度上都包括了研究参与者。在有整群层面研究参与者的20项试验亚组中,只有4项(20%)报告了获得此类参与者的知情同意;在有个体层面研究参与者的26项试验中,只有15项(58%)报告了他们的知情同意。超过三分之二的试验在群体层面实施干预(无论针对整群还是个体层面的参与者);9项试验(28%)没有从任何研究参与者那里收集到可识别的数据。总体而言,只有3项试验(9%)表明研究伦理委员会已批准豁免同意。在考虑研究伦理审查和知情同意(或豁免)的综合要求时,只有三分之一的研究符合要求。结论 阶梯楔形试验中关键伦理保护措施的伦理实施和报告,即研究伦理审查和知情同意,是不充分的。我们建议将阶梯楔形试验归类为研究并由研究伦理委员会进行审查和批准。我们还建议研究人员适当地识别研究参与者(可能包括卫生专业人员),寻求知情同意或向伦理委员会申请豁免同意,并在试验报告中包括研究伦理批准和知情同意的明确细节。